<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">83561</article-id><article-id pub-id-type="doi">10.7554/eLife.83561</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>B cell receptor induced IL-10 production from neonatal mouse CD19<sup>+</sup>CD43<sup>-</sup> cells depends on STAT5 mediated IL-6 secretion</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-294541"><name><surname>Sakai</surname><given-names>Jiro</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293843"><name><surname>Yang</surname><given-names>Jiyeon</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293844"><name><surname>Chou</surname><given-names>Chao-Kai</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293845"><name><surname>Wu</surname><given-names>Wells W</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-293048"><name><surname>Akkoyunlu</surname><given-names>Mustafa</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9958-4031</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Laboratory of Bacterial Polysaccharides</institution>, <institution>United States Food and Drug Administration</institution>, <addr-line><named-content content-type="city">Silver Spring</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Facility for Biotechnology Resources</institution>, <institution>United States Food and Drug Administration</institution>, <addr-line><named-content content-type="city">Silver Spring</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-61967"><name><surname>Kurosaki</surname><given-names>Tomohiro</given-names></name><role>Reviewing editor</role><aff><institution>Osaka University</institution>, <country>Japan</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>Mustafa.Akkoyunlu@fda.hhs.gov</email> (MA);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>03</day><month>02</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e83561</elocation-id><history><date date-type="received"><day>19</day><month>09</month><year>2022</year></date><date date-type="accepted"><day>31</day><month>01</month><year>2023</year></date></history><permissions><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0</ext-link> public domain dedication.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-83561-v1.pdf"/><abstract><p>Newborns are unable to reach the adult-level humoral immune response partly due to the potent immunoregulatory role of IL-10. Increased IL-10 production by neonatal B cells has been attributed to the larger population of IL-10-producting CD43<sup>+</sup> B-1 cells in neonates. Here, we show that neonatal mouse CD43<sup>-</sup> non-B-1 cells also produce substantial amounts of IL-10 following B cell antigen receptor (BCR) activation. In neonatal mouse CD43<sup>-</sup> non-B-1 cells, BCR engagement activated STAT5 under the control of phosphorylated forms of signaling molecules Syk, Btk, PKC, FAK and Rac1. Neonatal STAT5 activation led to IL-6 production, which in turn was responsible for IL-10 production in an autocrine/paracrine fashion through the activation of STAT3. In addition to the increased IL-6 production in response to BCR stimulation, elevated expression of IL-6Rα expression in neonatal B cells rendered them highly susceptible to IL-6 mediated STAT3 phosphorylation and IL-10 production. Finally, IL-10 secreted from neonatal mouse CD43<sup>-</sup> non-B-1 cells was sufficient to inhibit TNF-α secretion by macrophages. Our results unveil a distinct mechanism of IL-6-dependent IL-10 production in BCR-stimulated neonatal CD19<sup>+</sup>CD43<sup>-</sup> B cells.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><funding-statement>No external funding was received for this work.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: The mouse experiments described in this study were performed in accordance with the US Food and Drug Administration/Center for Biologics Evaluation and Research Institutional Animal Care and Use Committee guidelines (permit 2002-31 and 2017-45).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Sequencing data have been deposited in GEO under accession code GSE200955</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Sakai J</collab><collab>Chou C</collab><collab>Wu WW</collab><collab>Akkoyunlu M</collab></person-group><year iso-8601-date="2022">2022</year><source>Next Generation Sequencing analysis of BCR-induced gene expression in adult and neonatal splenic B cells</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE200955">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE200955</ext-link><comment>NCBI Gene Expression Omnibus, GSE200955</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-83561-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>